cupheadscratch| Novizan: Luciferase reporter gene detection reagent helps develop GLP-1RA drugs for "weight loss medicine"

Securities Times e Company NewscupheadscratchNovizan announced today that GLP-1 drugs have become the focus of the research and development of new obesity drugs due to their excellent clinical data and efficacy. Activity testing of GLP-1RA drugs is a key part of the drug development process. Currently, the mainstream method is the luciferase reporter gene method. Novizan can provide detection reagents and corresponding solutions to accelerate the progress of GLP-1RA drug research and development. Currently, it has supplied multiple GLP-1RA drug research and development projects that have entered the clinical stage.

Tags:

Prev: livboereepoker| The UK's CPI hit in April, or an unexpected upward trend suppressed the probability of interest rate cuts!
Next: wincryptobyplayinggames| Huilang Technology rose nearly 17% in the afternoon, Essence International maintains a "buy" rating